COMMUNIQUÉS West-GlobeNewswire

Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis
09/06/2026
Geleen, June 9, 2026 Matisse Pharmaceuticals B.V., a clinical stage company developing a medicinal product for the treatment of sepsis, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast [...]
Chiesi Global Rare Diseases Announces Health Canada Grants Priority Review for FILSUVEZ® (birch triterpenes) Topical Gel for the Treatment of Epidermolysis Bullosa
09/06/2026
Priority review recognizes the serious nature of epidermolysis bullosa (EB) and the urgent need for continued evaluation of potential treatment options If approved, FILSUVEZ has the potential to become the first therapy [...]
The MUHC Foundation’s Le Bal Rouge Gala raises $2,223,306 million to accelerate discovery in health care at the MUHC’s Glen site
09/06/2026
MONTREAL, June 09, 2026 (GLOBE NEWSWIRE) -- The MUHC Foundation’s signature gala, Le Bal Rouge , brought together Montreal’s most passionate leaders in business, philanthropy and health care to celebrate innovation at [...]
Le gala Le Bal Rouge de la Fondation du CUSM recueille un montant record de 2 223 306 $ pour accélérer les découvertes en santé au site Glen du CUSM
09/06/2026
MONTRÉAL, 09 juin 2026 (GLOBE NEWSWIRE) -- Le gala phare de la Fondation du CUSM, Le Bal Rouge, a réuni les leaders les plus engagés des milieux montréalais des affaires, de la philanthropie et de la santé pour célébrer [...]
Shattuck Labs Announces Exercise of Outstanding Common Stock Warrants and Provides Financial Update
09/06/2026
AUSTIN, Texas and DURHAM, N.C., June 09, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal [...]
Flyte Announces World Cup Activation Strategy, Targeting Global Travel Demand Surrounding 2026 Tournament
09/06/2026
Company Positions Platform to Capture High-Value Regional Travel Demand and Build Brand Exposure during Largest Global Sporting Event Northeast Corridor Routes Aligned with Key U.S. Host Markets to Drive Customer [...]
Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery
09/06/2026
ROCKAWAY, N.J., June 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the review article, "Without getting under your [...]
Vaxart to Participate in BTIG Infectious Disease Day 2026
09/06/2026
SOUTH SAN FRANCISCO, Calif., June 09, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery [...]
Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron (NS003)
09/06/2026
Study Comparing Intranasal Powder Formulation of Ondansetron Demonstrates Comparable Pharmacokinetic Profile to Intravenous Ondansetron in Animal Study; Program to Advance to First-in-Human PK Study in Third Quarter of [...]
Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma
09/06/2026
- BEACON2 is a landmark European multi-arm, multi-stage Phase 1/2 platform trial conducted and sponsored by the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham - Elraglusib will be assessed in [...]
BrainsWay Presents First SWIFT™ Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting
09/06/2026
Preliminary Data Analysis Reveals Over 80% Remission Rate One Year after Accelerated Deep TMS Treatment, with Decline in Severe Functional Impairment from 85% to 0% BURLINGTON, Mass. and JERUSALEM, June 09, 2026 (GLOBE [...]
CVRx Announces Chief Financial Officer Transition
09/06/2026
MINNEAPOLIS, June 09, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
TG Therapeutics Announces Positive Topline Phase 1 Data for Subcutaneous BRIUMVI in Patients with Myasthenia Gravis and Initiation of Potential Registration Directed Randomized Phase 2 Trial
09/06/2026
82% of subjects achieved an MCID in their MG-ADL with a mean >4 point improvement in MG-ADL observed in Phase 1 study of Subcutaneous BRIUMVI in patients with MG (n=11) Potential registration-directed Phase 2 trial [...]
Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China
09/06/2026
$13.5 million financing, including $5 million from Corvus, supports ongoing generation of soquelitinib clinical data in China for atopic dermatitis and asthma, which are indications also in development by Corvus in the [...]
Kraig Biocraft Laboratories Sets New All-Time Production Record, Delivering Nearly 2.5 Metric Tons of Recombinant Spider Silk in Single Production Cycle
09/06/2026
Company Continues Delivering on Aggressive 2026 Expansion Strategy as Production Scale Reaches New Heights ANN ARBOR, Mich., June 09, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the [...]
Alterity Therapeutics Achieves Alignment with U.S. FDA on Pivotal Phase 3 Program for ATH434 in Multiple System Atrophy
09/06/2026
– Successful End-of-Phase 2 meeting with FDA agreeing on key elements of the proposed Phase 3 design, including study population, dosing regimen, and treatment duration – – FDA agrees on UMSARS Part I as primary [...]
MitoRx Therapeutics Strengthens Leadership Team with C-Suite and Board Appointments to Support Next Phase of Growth
09/06/2026
Alison Strutt appointed as Chief Financial Officer, László Tank ó appointed as Consultant Chief Medical Officer, and Sam Fazeli appointed Non-Executive Director Appointments support MitoRx’s next phase of growth as the [...]
Antag Therapeutics Elects Keith Leonard as Chairman of its Board of Directors
09/06/2026
Antag Therapeutics Elects Keith Leonard as Chairman of its Board of Directors Copenhagen, Denmark, 09 June 2026 – Antag Therapeutics (“Antag” or “the Company”), advancing personalized and flexible obesity treatment [...]
DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference
09/06/2026
Châtillon, France, June 9, 2026 DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT) (the [...]

Pages